Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma

NCT01879085 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: Docetaxel
DRUG: Gemcitabine
DRUG: Vorinostat
DRUG: Pegfilgrastim

Sponsor

Melissa Burgess, MD

Collaborators

[object Object]